But the honest framing matters: it works through weight loss, it suits a specific group, and it complements rather than replaces both a diagnosis and standard therapy
The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms. An estimated 1.6 million UK adults used GLP-1s such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) to lose weight between early 2024 and early 2025, with an additional 3.3 million interested in using weight loss drugs during 2026
Currently, the Wegovy pen (injection) list price is $1,349 per month, though the company recently announced that it will reduce the price to $675 per month, starting in 2027
Clinical trials show that energy changes vary widelysome people feel noticeably more vital as excess weight lifts, while others initially experience fatigue during the body's metabolic adjustment phase
Dosing Table: What Is Actually Used and Why the Numbers Are Uncertain Body-weight scaling from rat studies (often cited as roughly 10 mcg per kg) produces doses in the several-hundred-microgram range for an average adult